AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (May 13, 2004). doi:10.1152/ajpheart.00222.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/3/H1344    most recent
00222.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Czarny, M.
Right arrow Articles by Schnitzer, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Czarny, M.
Right arrow Articles by Schnitzer, J. E.
Submitted on March 5, 2004
Accepted on May 11, 2004

Neutral Sphingomyelinase inhibitor scyphostatin prevents and ceramide mimics mechanotransduction in vascular endothelium

Malgorzata Czarny1 and Jan E. Schnitzer1*

1 Division of Vascular Biology and Angiogenesis Program, Sidney Kimmel Cancer Center, San Diego, CA, USA

* To whom correspondence should be addressed. E-mail: jschnitzer{at}skcc.org.

Recently, we showed that neutral sphingomyelinase (N-SMase) is concentrated at the endothelial cell surface in caveolae and is activated to produce ceramide in an acute and transient manner by increase in flow rate and pressure in rat lung vasculature (Czarny, M., Liu, J., Oh, P., and Schnitzer, J. E., 2003, J Biol Chem 278, 4424-4430). Here, we report further on our investigations of this new acute mechanotransduction pathway. We employed three different experimental models to explore the role of N-SMase and ceramides in mechanosignaling: 1) a cell-free, in vitro model using isolated luminal plasma membranes of rat lung endothelium; 2) a fluid shear stress model using monolayers of intact bovine aorta endothelial cell in culture; and 3) an in situ model using controlled perfusion of the rat lung vasculature. Scyphostatin, which specifically inhibited neutral but not acid sphingomyelinase activity, prevented mechano-activation of neutral sphingomyelinase as well as downstream tyrosine and mitogen activated protein kinases. Cell permeable ceramide analogs (N-acetylsphingosine, C2-ceramide and N-hexanoylsphingosine, C6-ceramide) but not the inactive, dihydro-derrivatives D2-ceramide and D6-ceramide (N-acetylsphinganine and N-hexanyolsphinganine, respectively) mimic rapid mechano-induced tyrosine phosphorylation of cell surface proteins, as well as mechano-activation of Src-like kinases and the extracellular regulated kinase pathway. The responses common to ceramide and mechanical stress were inhibited by genistein, herbamycin A, and PP2, but not PP3 which suggests an obligate role of Src-like kinases in ceramide-mediated mechanotransduction. Ceramides also induce serine/threonine phosphorylation to activate the Akt/endothelial nitric oxide synthase pathway. Thus, N-SMase at the plasma membrane in caveolae may be an upstream initiating mechanosensor, which acutely triggers mechanotransduction by generation of the lipid second messenger, ceramide.




This article has been cited by other articles:


Home page
J. Physiol.Home page
Q. Xiao, K. Yu, Y.-y. Cui, and H. C. Hartzell
Dysregulation of human bestrophin-1 by ceramide-induced dephosphorylation
J. Physiol., September 15, 2009; 587(18): 4379 - 4391.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Pavoine and F. Pecker
Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology
Cardiovasc Res, May 1, 2009; 82(2): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Venkataraman, Y.-M. Lee, J. Michaud, S. Thangada, Y. Ai, H. L. Bonkovsky, N. S. Parikh, C. Habrukowich, and T. Hla
Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate
Circ. Res., March 28, 2008; 102(6): 669 - 676.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.